Our History in Europe since 1994

Kaneka Pharma Europe NV was founded on October 31st, 1994 in Brussels, Belgium, as independent subsidiary of the parent company Kaneka Corporation in Japan to coordinate and execute distinct operations - like sales, distribution and marketing - concerning medical devices of Kaneka in the European, and later also Middle East, market.

In 1995, a German branch was established in Wiesbaden as a result of the constant improvement of the business. Subsequently, the Kaneka Pharma Europe NV German Branch moved to Eschborn where it still resides as of today.

In April 2004, Kaneka Pharma Europe NV added a further business segment, namely functional food.

As of March 31st, 2017 altogether 36 employees worked for Kaneka Pharma Europe NV, increasing steadily.

Innovation for health – Kaneka Pharma Europe NV

In addition to lipid apheresis Kaneka Pharma Europe NV is continuously expanding its business activities including exclusive distribution of some non-Kaneka devices.

  • 2001 – Launch of the LIPOSORBER® D DL-75 whole blood apheresis system.
  • 2003 – Introduction of the next generation apheresis machines, DX-21 and MA-03.
  • 2004 – Launch of the LIPOSORBER® D DL-100 whole blood apheresis system.
  • 2007 – Launch of the Thrombuster thrombus aspiration device.
  • 2008 – Launch of the Crusade dual-lumen catheter.
  • 2011 – Launch of the LIXELLE® ß2-microglobulin column.
  • 2013 – Launch of CellEffic BM, a BM-MSC separation device.
  • 2015 – Launch of CellEffic CB, a cord blood processing device.
  • 2015 – Launch of the ED Coil aneurysm coil.
  • 2015 – Start distributing the Remedy bioresorbable vascular scaffold.
  • 2016 – Start distributing the SensiLase PAD-IQ® skin perfusion pressure device.
  • 2016 – Start distributing the Novaerus airborne infection control devices.

In an ongoing process, Kaneka is developing innovative medical devices aimed at improving the lives of people.